Mythbuster: Time To Ditch Mid-Year Chemo Replacement Codes

Why This Topic Matters

These updates affect whether claims for IVIG-related services are accepted or denied, making the article relevant for reducing claim rejections and aligning billing with current Medicare guidance.

Article Sections

1. Reporting Q4087 for IVIG? Not anymore

   Introduces the billing update for immune globulin services and summarizes the shift away from the previously used Q series. Provides the Medicare context for the change.

2. Use Specific IVIG J-Code

   Reviews the move to more specific HCPCS drug coding for immune globulin products and references related CMS guidance. Includes discussion of the pre-administration service associated with IVIG billing.

3. Don't Forget Administration Code

   Covers the infusion administration coding associated with IVIG claims and notes which general category of codes should be avoided for this service. Includes a brief illustrative example and a reminder about reporting limits for the pre-administration code.